Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsReceivables - NetReceivables - Other
Ratios

Connect Biopharma Holdings (CNTB) Accumulated Depreciation & Amortization (2023 - 2024)

Connect Biopharma Holdings' Accumulated Depreciation & Amortization history spans 2 years, with the latest figure at $660000.0 for Q4 2024.

  • For Q4 2024, Accumulated Depreciation & Amortization fell 8.33% year-over-year to $660000.0; the TTM value through Dec 2024 reached $660000.0, down 8.33%, while the annual FY2024 figure was $660000.0, 8.33% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2024 was $660000.0 at Connect Biopharma Holdings, down from $720000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $720000.0 in Q4 2023 and bottomed at $660000.0 in Q4 2024.